News & events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

OncoArendi Therapeutics Gets Listed

18 December 2017

OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines

9 October 2017

OncoArendi featured in Labiotech.eu

19 July 2017

OncoArendi Therapeutics announced today that it has filed a Clinical Trial Application (CTA)

7 July 2017

OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers

21 June 2017

Events & Presentations

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018

ERS International Congress 2018 – Paris, France 15-19.09.2018

14 September 2018

54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.

17 July 2018

ATS 2018, 18 – 23 May, San Diego, USA

21 May 2018

ESMO Immuno Oncology Congress Geneva – December 7-10

1 December 2017

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017

1 October 2017